Clare Gerrard, Author at Neuroendocrine Cancer UK

Patients and public are important stakeholders in health technology assessment but the level of involvement is low

by Clare Gerrard | Jan 20, 2021

Patients and public are important stakeholders in health technology assessment but the level of involvement is low – a call to action. Health technology assessment (HTA) agencies have an important role in the evaluation and approval of new technologies. They determine...

Patients gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era

by Clare Gerrard | Jan 20, 2021

Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era. Read full journal here

COVID and Vitamin D

by Clare Gerrard | Jan 14, 2021

There are various reports circulating about vitamin D and COVID, which may appear to be contradictory, so what is the recommended advice ? : It is apparent is that vitamin D can be a good marker for overall health – and that those with low levels or...

Government shielding advice in England

by Clare Gerrard | Jan 13, 2021

For information: Government shielding advice in England (5 Jan) Dear all Following the Prime Minister’s announcement last week, the Government has reintroduced shielding advice for people who are Clinically Extremely Vulnerable (CEV) from Covid-19 across all areas of...

Looking for Patient volunteers with a small bowel primary and liver metastases

by Clare Gerrard | Jan 7, 2021

A randomised control trial is being set up across many sites in the UK, led by Mr Samuel Ford, a consultant surgeon at the Queen Elizabeth Hospital in Birmingham. This trial is looking at the role of surgery in patients with small bowel neuroendocrine cancers with...

Patients and public are important stakeholders in health technology assessment but the level of involvement is low

Patients gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era

COVID and Vitamin D

Government shielding advice in England

Looking for Patient volunteers with a small bowel primary and liver metastases

About Us

Subscribe

Contact

Helpline: 0800 434 6476

Office: 01926 883 487

Holly House, 74 Upper Holly Walk, Leamington Spa CV32 4JL

Email us